“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” Inari had been working with advisers to ...
Many people delayed elective procedures at the height of the pandemic. BTIG's Thibault notes analysts expect Inari Medical to report greater than 20% sales growth for 2024. Importantly ...
Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...
“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” “Inari has positively impacted the ...
Inari’s stock price closed at $65 Monday ... patients and will accelerate Stryker’s impact in endovascular procedures.” While the Inari purchase continues an active run of acquisitions ...
The Cambridge-based seed design company also raised one of the largest venture capital rounds for Massachusetts tech companies in 2024. Cambridge-based seed design company Inari Agriculture Inc ...
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Inari shareholders are getting a fair price relative to the ...
“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.” “Inari has positively impacted the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback